These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2244814)

  • 1. Detection of primary colorectal cancer with indium 111 monoclonal antibody B72.3.
    Doerr RJ; Abdel-Nabi H; Baker JM; Steinberg S
    Arch Surg; 1990 Dec; 125(12):1601-5. PubMed ID: 2244814
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In-111 CYT-103 monoclonal antibody imaging in patients with suspected recurrent colorectal cancer.
    Doerr RJ; Herrera L; Abdel-Nabi H
    Cancer; 1993 Jun; 71(12 Suppl):4241-7. PubMed ID: 8508386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.
    Petersen BM; Bass BL; Bates HR; Chandeysson PL; Harmon JW
    Am J Surg; 1993 Jan; 165(1):137-42; discussion 142-3. PubMed ID: 8418688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indium 111 ZCE-025 immunoscintigraphy in occult recurrent colorectal cancer with elevated carcinoembryonic antigen level.
    Doerr RJ; Abdel-Nabi H; Merchant B
    Arch Surg; 1990 Feb; 125(2):226-9. PubMed ID: 2302062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.
    Yokoyama K; Carrasquillo JA; Chang AE; Colcher D; Roselli M; Sugarbaker P; Sindelar W; Reynolds JC; Perentesis P; Gansow OA
    J Nucl Med; 1989 Mar; 30(3):320-7. PubMed ID: 2738661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indium-111 monoclonal antibody B72.3 scintigraphy in colorectal cancer. Correlation with computed tomography, surgery, histopathology, immunohistology, and human immune response.
    Winzelberg GG; Grossman SJ; Rizk S; Joyce JM; Hill JB; Atkinson DP; Sudina K; Anderson K; McElwain D; Jones AM
    Cancer; 1992 Apr; 69(7):1656-63. PubMed ID: 1551051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose escalation trial of indium-111-labeled anti-carcinoembryonic antigen chimeric monoclonal antibody (chimeric T84.66) in presurgical colorectal cancer patients.
    Wong JY; Chu DZ; Yamauchi D; Odom-Maryon TL; Williams LE; Liu A; Esteban JM; Wu AM; Primus FJ; Beatty JD; Shively JE; Raubitschek AA
    J Nucl Med; 1998 Dec; 39(12):2097-104. PubMed ID: 9867150
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal carcinoma metastases: detection with In-111-labeled monoclonal antibody CCR 086.
    Abdel-Nabi HH; Levine G; Lamki LM; Murray JL; Tauxe WN; Shah AN; Patt YZ; Doerr RJ; Klein HA; Gona J
    Radiology; 1990 Jul; 176(1):117-22. PubMed ID: 2353080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoscintigraphy of colorectal carcinoma utilizing 111In-labeled monoclonal antibody conjugate CYT-103.
    Neal CE; Swan TL; Baker MR; Ellis RL; Katterhagen JG
    Gastrointest Radiol; 1991; 16(3):251-5. PubMed ID: 1879645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoscintigraphy of primary colorectal cancers with indium-111 monoclonal antibody B72.3.
    Joypaul BV; Kennedy N; Hanson J; Holley M; Browning M; Newman EL; Cuschieri A
    J R Coll Surg Edinb; 1994 Feb; 39(1):39-43. PubMed ID: 7515429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imaging with indium111-labeled anticarcinoembryonic antigen monoclonal antibody ZCE-025 of recurrent colorectal or carcinoembryonic antigen-producing cancer in patients with rising serum carcinoembryonic antigen levels and occult metastases.
    Patt YZ; Lamki LM; Shanken J; Jessup JM; Charnsangavej C; Ajani JA; Levin B; Merchant B; Halverson C; Murray JL
    J Clin Oncol; 1990 Jul; 8(7):1246-54. PubMed ID: 2193120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-111-labeled monoclonal antibody immunoscintigraphy in colorectal carcinoma: safety, sensitivity, and preliminary clinical results.
    Abdel-Nabi H; Doerr RJ; Chan HW; Balu D; Schmelter RF; Maguire RT
    Radiology; 1990 Apr; 175(1):163-71. PubMed ID: 2315476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal tumors: scintigraphy with In-111 anti-CEA monoclonal antibody and correlation with surgical, histopathologic, and immunohistochemical findings.
    Abdel-Nabi HH; Schwartz AN; Goldfogel G; Ortman-Nabi JA; Matsuoka DM; Unger MW; Wechter DG
    Radiology; 1988 Mar; 166(3):747-52. PubMed ID: 3277244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lesion-by-lesion comparison of computerized tomography and indium-111-labeled monoclonal antibody C110 radioimmunoscintigraphy in colorectal carcinoma: a multicenter trial.
    Divgi CR; McDermott K; Griffin TW; Johnson DK; Schnobrich KE; Fallone PS; Scott AM; Hilton S; Cohen AM; Larson SM
    J Nucl Med; 1993 Oct; 34(10):1656-61. PubMed ID: 8410278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoscintigraphy with a new indium-111-labeled monoclonal antibody (MAb 1A3) in patients with colorectal cancer.
    Philpott GW; Siegel BA; Schwarz SW; Connett JM; Rocque PA; Fleshman JW; Wallis JW; Baumann M; Sun Y; Martell AE
    Dis Colon Rectum; 1994 Aug; 37(8):782-92. PubMed ID: 8055723
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Colorectal carcinoma: detection with indium-111 anticarcinoembryonic-antigen monoclonal antibody ZCE-025.
    Abdel-Nabi HH; Schwartz AN; Higano CS; Wechter DG; Unger MW
    Radiology; 1987 Sep; 164(3):617-21. PubMed ID: 3303117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 111In-CYT-103 scanning in recurrent colorectal cancer--does it affect standard management?
    Dominguez JM; Wolff BG; Nelson H; Forstrom LA; Mullan BP
    Dis Colon Rectum; 1996 May; 39(5):514-9. PubMed ID: 8620800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Initial clinical study of indium-111-labeled clone 110 anticarcinoembryonic antigen antibody in patients with colorectal cancer.
    Griffin TW; Brill AB; Stevens S; Collins JA; Bokhari F; Bushe H; Stochl MC; Gionet M; Rusckowski M; Stroupe SD
    J Clin Oncol; 1991 Apr; 9(4):631-40. PubMed ID: 2066759
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multicenter clinical trials of monoclonal antibody B72.3-GYK-DTPA 111In (111In-CYT-103; OncoScint CR103) in patients with colorectal carcinoma.
    Abdel-Nabi HH; Doerr RJ
    Targeted Diagn Ther; 1992; 6():73-88. PubMed ID: 1576351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of hepatic metastases from colorectal carcinoma using indium-111 (111In) labeled monoclonal antibody (mAb): MSKCC experience with mAb 111In-C110.
    Divgi CR; McDermott K; Johnson DK; Schnobrich KE; Finn RD; Cohen AM; Larson SM
    Int J Rad Appl Instrum B; 1991; 18(7):705-10. PubMed ID: 1787079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.